Beaurang Pierre

Track

Insider profile

Beaurang Pierre's trades of Nurix Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-11 2021-06-10
PlS Planned sale
80,373 -4.2%
129.76
US$4,246,916 		80,373 -4.2% 129.76 US$4,246,916
2021-06-11 2021-06-10
PlS Planned sale
3,380 -44.5%
311.58
US$3,186,551 		3,380 -44.5% 311.58 US$3,186,551
2021-06-11 2021-06-10
PlS Planned sale
47,251 +21.6%
298.19
US$484,104 		47,251 +21.6% 298.19 US$484,104
2021-04-13 2021-04-12
PlS Planned sale
545 -11.2%
28.65
US$15,617 		545 -11.2% 28.65 US$15,617
2021-04-13 2021-04-12
PlS Planned sale
2,883 -37.2%
27.67
US$79,770 		2,883 -37.2% 27.67 US$79,770
2021-04-13 2021-04-12
PlS Planned sale
4,072 -34.4%
26.83
US$109,245 		4,072 -34.4% 26.83 US$109,245
2021-03-09 2021-03-08
PlS Planned sale
200 -100.0%
38.34
US$7,668 		200 -100.0% 38.34 US$7,668
2021-03-09 2021-03-08
PlS Planned sale
4,490 -95.7%
37.31
US$167,504 		4,490 -95.7% 37.31 US$167,504
2021-03-09 2021-03-08
PlS Planned sale
2,810 -37.5%
36.48
US$102,507 		2,810 -37.5% 36.48 US$102,507
2021-02-22 2021-02-18
PlS Planned sale
400 -100.0%
37.88
US$15,150 		400 -100.0% 37.88 US$15,150
2021-02-22 2021-02-18
PlS Planned sale
1,000 -71.4%
36.92
US$36,924 		1,000 -71.4% 36.92 US$36,924
2021-02-22 2021-02-18
PlS Planned sale
6,400 -82.1%
35.99
US$230,328 		6,400 -82.1% 35.99 US$230,328
2021-02-22 2021-02-18
PlS Planned sale
4,553 -36.9%
35.02
US$159,454 		4,553 -36.9% 35.02 US$159,454
2021-02-22 2021-02-18
PlS Planned sale
2,647 -17.6%
34.19
US$90,496 		2,647 -17.6% 34.19 US$90,496